微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.34% | 24.56% | -65.82% | 5/69 | 2.26% | 沃华医药 | 5.94% | 行业排名> |
| 2024-12-31 | 18.55% | 37.61% | 22.6% | 5/69 | 3.28% | 天目药业 | 9.27% | 行业排名> |
| 2024-09-30 | 15.13% | 45.2% | 46.32% | 4/69 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-06-30 | 10.34% | 47.71% | 103.14% | 6/69 | 0.67% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-03-31 | 5.09% | 43.79% | -62.24% | 11/69 | 1.53% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-12-31 | 13.48% | -2.95% | 29.37% | 12/69 | 0.11% | 片仔癀 | 7.03% | 行业排名> |
| 2023-09-30 | 10.42% | -0.29% | 48.86% | 19/69 | 7.26% | 片仔癀 | 23.1% | 行业排名> |
| 2023-06-30 | 7% | 1.3% | 97.74% | 16/69 | 4.93% | 太极集团 | 22.08% | 行业排名> |
| 2023-03-31 | 3.54% | -3.28% | -74.51% | 27/69 | 3.21% | 太极集团 | 17.13% | 行业排名> |
| 2022-12-31 | 13.89% | 32.92% | 32.92% | 10/69 | 6.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-09-30 | 10.45% | 38.04% | 51.23% | 17/69 | 5.16% | *ST吉药 | 72.63% | 行业排名> |
| 2022-06-30 | 6.91% | 42.18% | 88.8% | 15/69 | 3.2% | 片仔癀 | 23.54% | 行业排名> |
| 2022-03-31 | 3.66% | 35.56% | -64.98% | 14/69 | 2.18% | 片仔癀 | 19.69% | 行业排名> |
| 2021-12-31 | 10.45% | 68.01% | 38.04% | 25/69 | 4.54% | 片仔癀 | 12.75% | 行业排名> |
| 2021-09-30 | 7.57% | 62.1% | 55.76% | 32/69 | 7.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-06-30 | 4.86% | 120.91% | 80% | 29/69 | 4.68% | 片仔癀 | 27.39% | 行业排名> |
| 2021-03-31 | 2.7% | 225.3% | -56.59% | 28/69 | 2.7% | 片仔癀 | 23.14% | 行业排名> |
| 2020-12-31 | 6.22% | 393.65% | 33.19% | 39/69 | 0.1% | 片仔癀 | 13.23% | 行业排名> |
| 2020-09-30 | 4.67% | 59.39% | 112.27% | 45/69 | 6.79% | *ST长药 | 7.37% | 行业排名> |
| 2020-06-30 | 2.2% | 15.18% | 165.06% | 47/69 | 3.75% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 0.83% | 2.47% | -34.13% | 52/69 | 2.14% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 1.26% | 407.32% | -57% | 54/69 | 5.86% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 2.93% | -22.89% | 53.4% | 51/69 | 7.3% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 1.91% | -12.79% | 135.8% | 53/69 | 4.72% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 0.81% | 22.73% | 297.56% | 59/69 | 2.92% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | -0.41% | -116.73% | -110.79% | 59/69 | 7.87% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 3.8% | 0% | 73.52% | 50/69 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 2.19% | -26.76% | 231.82% | 50/69 | 5.03% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 0.66% | -15.38% | -73.06% | 58/69 | 2.75% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 2.45% | -43.16% | -35.53% | 60/69 | 9.93% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 3.8% | -32.62% | 27.09% | 54/69 | 8.39% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 2.99% | -21.73% | 283.33% | 49/69 | 5.24% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 0.78% | -56.18% | -81.9% | 52/69 | 2.62% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 4.31% | -35.58% | -23.58% | 56/69 | 10.02% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 5.64% | -14.8% | 47.64% | 40/69 | 9.32% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 3.82% | -33.45% | 114.61% | 44/69 | 5.04% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 1.78% | -28.8% | -73.39% | 40/69 | 4.1% | 维康药业 | 38.23% | 行业排名> |
| 2015-12-31 | 6.69% | -46.39% | 1.06% | 46/69 | 11.34% | 太极集团 | 58.41% | 行业排名> |
| 2015-09-30 | 6.62% | -26.2% | 15.33% | 35/69 | 8.44% | 新光药业 | 16.54% | 行业排名> |
| 2015-06-30 | 5.74% | -0.69% | 129.6% | 30/69 | 5.48% | 太极集团 | 71.6% | 行业排名> |
| 2015-03-31 | 2.5% | 20.77% | -79.97% | 35/69 | 2.9% | 维康药业 | 48.67% | 行业排名> |